DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Joensuu H, Fraser J, Wildiers H. et al.
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs. 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
JAMA Oncol 2018;
DOI: 10.1001/jamaoncol.2018.1380.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.